CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Monday reported fourth-quarter earnings of $11.1 million.
On a per-share basis, the Chicago-based company said it had net income of 6 cents.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 3 cents per share.
The company posted revenue of $85.8 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $81.4 million.
For the year, the company reported profit of $554,000. Revenue was reported as $291.8 million.
Xeris Biopharma expects full-year revenue in the range of $375 million to $390 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS